Syndax Pharmaceuticals Inc (SNDX)
19.27
-0.02
(-0.10%)
USD |
NASDAQ |
May 31, 16:00
19.25
-0.02
(-0.10%)
After-Hours: 20:00
Syndax Pharmaceuticals Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2021 | 139.71M |
| December 31, 2020 | 1.517M |
| December 31, 2019 | 1.517M |
| December 31, 2018 | 1.517M |
| Date | Value |
|---|---|
| December 31, 2017 | 2.108M |
| December 31, 2016 | 1.22M |
| December 31, 2015 | 0.627M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.517M
Minimum
2019
139.71M
Maximum
2021
47.58M
Average
1.517M
Median
2019
Revenue (Annual) Benchmarks
| Geron Corp | 0.237M |
| Verastem Inc | -- |
| Karyopharm Therapeutics Inc | 146.03M |
| Crinetics Pharmaceuticals Inc | 4.013M |
| Arvinas Inc | 78.50M |